Madrigal Pharmaceuticals SG&A Expense (TTM) Insights

Madrigal Pharmaceuticals Inc (MDGL)

220.06 +2.89 (+1.33%) USD | NASDAQ | May 17, 16:00

220.06 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2007. Upgrade now.

Date	Value
March 31, 2024	172.76M
December 31, 2023	108.15M
September 30, 2023	76.17M
June 30, 2023	60.72M
March 31, 2023	54.65M
December 31, 2022	48.13M
September 30, 2022	45.28M
June 30, 2022	41.43M
March 31, 2022	39.77M
December 31, 2021	37.32M
September 30, 2021	31.73M
June 30, 2021	28.94M
March 31, 2021	24.47M
December 31, 2020	21.86M
September 30, 2020	20.78M
June 30, 2020	20.04M
March 31, 2020	21.51M
December 31, 2019	22.65M
September 30, 2019	23.19M
June 30, 2019	23.56M
March 31, 2019	19.17M
December 31, 2018	15.29M
September 30, 2018	12.11M
June 30, 2018	8.942M
March 31, 2018	7.848M

Date	Value
December 31, 2017	7.672M
September 30, 2017	7.505M
June 30, 2017	11.84M
March 31, 2017	10.76M
December 31, 2016	9.29M
September 30, 2016	7.203M
June 30, 2016	1.116M
March 31, 2016	3.692M
December 31, 2015	7.620M
September 30, 2015	11.72M
June 30, 2015	14.76M
March 31, 2015	14.57M
December 31, 2014	15.75M
September 30, 2014	14.97M
June 30, 2014	15.90M
March 31, 2014	17.14M
December 31, 2013	15.70M
September 30, 2013	15.59M
June 30, 2013	14.21M
March 31, 2013	12.91M
December 31, 2012	11.68M
September 30, 2012	11.13M
June 30, 2012	11.46M
March 31, 2012	11.53M
December 31, 2011	11.55M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

20.04M

Minimum

Jun 2020

172.76M

Maximum

Mar 2024

46.16M

Average

34.52M

Median

SG&A Expense (TTM) Benchmarks